Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, OGT Expand Array, Target Enrichment Partnership in New Deal

Premium

By Justin Petrone

Agilent Technologies will provide Oxford Gene Technology with oligonucleotide microarrays and SureSelect target enrichment products for use in OGT's next-generation sequencing services, the companies said this week.

The new agreement expands on an earlier pact inked in 2007, in which Agilent agreed to manufacture OGT-designed arrays for the British firm's customers, and OGT became an Agilent-certified service provider for the Santa Clara, Calif.-based life science tools vendor's microarrays. OGT was later certified as a high-throughput services provider, the only such firm to receive such a designation to date (BAN 3/2/2010).

According to OGT CEO Mike Evans, the deal with Agilent is exclusive in that OGT is compelled to offer Agilent arrays or SureSelect target enrichment products "unless the customer's specific requirements cannot be met with the existing Agilent product range."

In a statement, Evans characterized the pact as a "long-term agreement" that "enables OGT to offer its customers Agilent's ... product range at competitive prices within its ... microarray and sequencing services."

OGT introduced its sequencing services offering, called Genefficiency, earlier this year (BAN 5/13/2011). The company offers a menu of arrays for cytogeneticists called CytoSure, all of which are manufactured by Agilent. In addition to DNA arrays, OGT also maintains an internal protein array program that it gained through its acquisition of Sense Proteomic in 2008 (BAN 3/17/2009).

Further terms of the recent agreement were not available.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.